Doloxe

Doloxe, founded in the early 2020s, has positioned itself as a specialized AI-driven platform for the pharmaceutical and biotech industries.

Reviewed by 7wData
Share Email

On this page

Profile

Doloxe provides AI-driven tools for drug research, clinical trials, and regulatory data management.

Doloxe, founded in the early 2020s, has positioned itself as a specialized AI-driven platform for the pharmaceutical and biotech industries. The company focuses on integrating generative AI to streamline drug research, clinical trials, and regulatory data management. Doloxe’s product suite includes tools like BioPharmaKSM, which tracks over 12,000 drug manufacturers and 18,000 facilities globally, and 360BioPharmaTracker, which monitors 30,000+ drug developments and corporate deals.

The company’s Clinical Trials Accelerators platform claims to improve trial operational efficiency by 72%, reducing costs and timelines. Doloxe’s Reformulation & Repurpose Platform, trained on 10,000+ pipeline and approved drugs, recommends drugs eligible for repurposing or reformulation based on scientific, commercial, and technological parameters. The HEOR Tracker provides insights into therapy costs, health technology assessments, and drug pricing mechanisms.

Doloxe’s customer base primarily includes pharmaceutical companies, biotech firms, and regulatory bodies. The company has not disclosed specific financials or funding rounds publicly, but its focus on AI-driven solutions in a highly regulated industry has garnered attention. Recent developments suggest Doloxe is expanding its AI capabilities to include dynamic model updates based on new drug approvals and research. The company’s ability to integrate vast datasets and provide actionable insights in real-time is its key differentiator.

Track Doloxe and 240+ vendors.

335k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Who buys this

  • Pharmaceutical companies
  • Biotech firms
  • Regulatory bodies
  • Clinical research organizations
  • Health technology assessment agencies

Strengths and what to watch

Strengths

  • Comprehensive tracking of drug manufacturers, facilities, and active ingredients globally
  • AI-driven recommendations for drug repurposing and reformulation
  • Significant improvement in clinical trial operational efficiency

Watch for

  • Limited public disclosure of financials and funding rounds
  • High dependency on AI models trained on historical data
  • Potential regulatory challenges in the pharmaceutical industry

Key Information

Founded
2020

Frequently Asked Questions

What does Doloxe do?

Doloxe provides AI-driven tools for drug research, clinical trials, and regulatory data management. Their platforms streamline pharmaceutical processes, offering solutions like global drug tracking, clinical trial efficiency improvements, and AI-based recommendations for drug repurposing and reformulation.

How does Doloxe improve clinical trial efficiency?

Doloxe’s Clinical Trials Accelerators platform claims to improve trial operational efficiency by 72%, reducing costs and timelines. It integrates AI to optimize processes, ensuring faster and more cost-effective clinical trials for pharmaceutical companies and biotech firms.

What is Doloxe’s approach to drug repurposing?

Doloxe’s Reformulation & Repurpose Platform uses AI to analyze over 10,000 pipeline and approved drugs, recommending candidates for repurposing or reformulation. It evaluates scientific, commercial, and technological parameters to identify viable opportunities for pharmaceutical innovation.

Who uses Doloxe’s platforms?

Doloxe’s customer base includes pharmaceutical companies, biotech firms, regulatory bodies, clinical research organizations, and health technology assessment agencies. Their tools cater to industries requiring advanced AI-driven solutions for drug research, clinical trials, and regulatory compliance.

What tools does Doloxe offer for global drug tracking?

Doloxe offers BioPharmaKSM, which tracks over 12,000 drug manufacturers and 18,000 facilities globally, and 360BioPharmaTracker, which monitors 30,000+ drug developments and corporate deals. These tools provide comprehensive insights into global pharmaceutical activities.

How does Doloxe handle regulatory data management?

Doloxe integrates AI to streamline regulatory data management, offering real-time insights and actionable recommendations. Their platforms ensure compliance with pharmaceutical regulations, helping companies manage complex data efficiently and meet industry standards.

Sources

  1. doloxe.com — Integrated GenAI Search for drug research and clinical data
  2. doloxe.com — BioPharmaKSM tracks drug manufacturers and facilities globally
  3. doloxe.com — 360BioPharmaTracker monitors drug developments and corporate deals
  4. doloxe.com — Clinical Trials Accelerators improve trial operational efficiency
  5. doloxe.com — Reformulation & Repurpose Platform recommends drugs for repurposing
  6. doloxe.com — HEOR Tracker provides insights into therapy costs and HTAs